STER
STERLING CHECK CORP
No data for this timeframe.
Vol
Inst. Holders5 funds
Inst. Value$10.8M
Inst. Activity0 buys / 5 sells
SEC Reports1
Recent Activity
Feb 28, 2026
SEC
Three major passive institutional investors — Morgan Stanley, Wells Fargo, and Schwab — fully exited their positions in
INST-CLUSTER — Impact 6/10
Inst.
CHARLES SCHWAB INVESTMENT MANAGEMENT — EXIT
0 shares ($0.00)
Inst.
UBS Group AG — EXIT
0 shares ($0.00)
Analyst Ratings
0Strong Buy
0Buy
8Hold
1Sell
2Strong Sell
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $4.6M | EXIT |
| MORGAN STANLEY | $3.7M | EXIT |
| UBS Group AG | $2.1M | EXIT |
| CITADEL ADVISORS LLC | $234.7K | EXIT |
| WELLS FARGO & COMPANY/MN | $205.8K | EXIT |
5 institutional holders with $10.8M total value (647,062 shares) as of 2024-Q3. Top holders: CHARLES, MORGAN, UBS. Net buying activity: 2 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2024-Q3
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 277,751 | $4.6M | 42.9% | EXIT -100.0% |
| 2 | MORGAN STANLEY | 218,604 | $3.7M | 33.8% | EXIT -100.0% |
| 3 | UBS Group AG | 124,362 | $2.1M | 19.2% | EXIT -100.0% |
| 4 | CITADEL ADVISORS LLC | 14,037 | $234.7K | 2.2% | EXIT -100.0% |
| 5 | WELLS FARGO & COMPANY/MN | 12,308 | $205.8K | 1.9% | EXIT -100.0% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | EXIT | 277,751 | 0 | -100.0% | $0.00 | 2024-Q4 |
| UBS Group AG | EXIT | 124,362 | 0 | -100.0% | $0.00 | 2024-Q4 |
| MORGAN STANLEY | EXIT | 218,604 | 0 | -100.0% | $0.00 | 2024-Q4 |
| CITADEL ADVISORS LLC | EXIT | 14,037 | 0 | -100.0% | $0.00 | 2024-Q4 |
| WELLS FARGO & COMPANY/MN | EXIT | 12,308 | 0 | -100.0% | $0.00 | 2024-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 277,751 | — | $4.6M | 2024-Q3 |
| MORGAN STANLEY | DOUBLED | 59,800 | 218,604 | +265.6% | $3.7M | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
1 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 0 neutral. Avg impact: 6.0/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 0% buy across 11 analysts — 0 strong buy, 0 buy, 8 hold, 1 sell, 2 strong sell. No current recommendation available.
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jan 1, 2025 | 0 | 0 | 8 | 1 | 2 | 0% | |
| Dec 1, 2024 | 0 | 0 | 8 | 1 | 2 | 0% | |
| Nov 1, 2024 | 0 | 0 | 10 | 1 | 2 | 0% | |
| Oct 1, 2024 | 0 | 0 | 10 | 1 | 2 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.